Search

everythinglearnresearchcommunity

for

Search:↓

New drug delivery methods can make natural compounds more effective and stable.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

A cat with skin bumps and itching had high blood fats and skin infections, which improved with diet and medication changes.

Vitamin D is crucial for bone health and preventing serious diseases.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

The study successfully formulated and optimized a bilayer tablet combining Tamsulosin and Finasteride using response surface methodology.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Minoxidil effectively treats severe hypertension but may cause side effects, so careful monitoring is needed.

Tamarix aphylla may be effective for various medical conditions, but more research is needed to confirm its safety and effectiveness.

Hydroxychloroquine can help treat certain types of hair loss.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The conclusion is that hair supplement ingredients may be unsafe and should be disclosed and proven safe before use.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Cobalt is important for health but too much or too little can cause health problems, and its environmental buildup is a concern.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.